TCJL37 is a potent, selective, and orally bioavailable TYK2 inhibitor with a Ki of 1.6 nM. TCJL37 can be used for the research of inflammatory bowel diseases (IBD)[1].
Molecular Weight:
376.74
Purity:
99.89
CAS Number:
[1258294-34-6]
Formula:
C17H11ClF2N4O2
Target:
JAK
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
